Defining the gold standard for building safe and effective synthetic data in the EU and beyond.

We aim to deliver a range of impactful outcomes through a strategic and collaborative approach. Our consortium will establish a comprehensive legal, ethical, and regulatory framework to support the responsible and accelerated adoption of synthetic data (SD) in healthcare, especially for regulatory decision-making. It will create a clinical-grade SD cohort tailored to our six use cases and validate its application in real-world clinical settings.

We are committed to ensuring that its research and results are accessible to healthcare stakeholders globally, promoting transparency and inclusivity. Additionally, the project will leverage SD to improve patient access to innovative drugs, tools, and medical devices, thereby supporting the development of precision medicine while preserving the sustainability of healthcare systems across the EU.

The expected impact of SYNTHIA includes broader access to interoperable SD methodologies and datasets that fuel research and innovation. It will enhance understanding of patients with chronic and complex conditions by integrating m-health and e-health technologies. Advanced analytics and AI tools will be deployed to support health research, leading to better clinical decision support, more accurate diagnoses, faster development of personalized interventions, and stronger, less biased evidence for evaluating new digital health and AI solutions.

All of our publications are available on a dedicated page, but SYNTHIA’s impact extends well beyond written outputs. You can also explore how we connect and engage with the community — both in person and online — through our Meet Us page.